Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -219.36% is 84% below its 5-year average of -119.09%, near the high end of its 5-year range (-4407.80%–-31.43%).
As of the fiscal period ended Tuesday, June 30, 2026. 86.25% above its 12-month average of -1595.51%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -219.36%.
RETURN ON INVESTED CAPITAL (ROIC)
-219.36%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-1595.51%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-649.28%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-119.09%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-121.28%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+86.25%
CURRENT VS 3Y AVG
+66.21%
CURRENT VS 5Y AVG
-84.19%
CURRENT VS 10Y AVG
-80.88%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-28.69%
median of 489 covered companies
CURRENT VS SECTOR MEDIAN
-664.59%
vs the sector median at left
Artelo Biosciences, Inc.
Market Cap
$1.36M
Return on Invested Capital (ROIC)
-219.36%
TTM Avg
-1595.51%
3Y Avg
-649.28%
5Y Avg
-119.09%
Market Cap
$1.37M
Return on Invested Capital (ROIC)
-107.08%
TTM Avg
-750.62%
3Y Avg
-506.81%
5Y Avg
-355.90%
Market Cap
$1.48M
Return on Invested Capital (ROIC)
-28.43%
TTM Avg
-37.81%
3Y Avg
-267.17%
5Y Avg
-197.37%
Market Cap
$1.49M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-48.91%
3Y Avg
-66.07%
5Y Avg
-87.70%
Market Cap
$1.50M
Return on Invested Capital (ROIC)
-163.98%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.54M
Return on Invested Capital (ROIC)
-567.17%
TTM Avg
-332.51%
3Y Avg
-201.53%
5Y Avg
-141.19%
Market Cap
$1.17M
Return on Invested Capital (ROIC)
-709.40%
TTM Avg
-164.13%
3Y Avg
-164.13%
5Y Avg
-164.13%
Market Cap
$1.17M
Return on Invested Capital (ROIC)
-128.95%
TTM Avg
-69.60%
3Y Avg
-67.51%
5Y Avg
-50.89%
Market Cap
$1.14M
Return on Invested Capital (ROIC)
-9.45%
TTM Avg
-4.19%
3Y Avg
5.39%
5Y Avg
5.39%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Artelo Biosciences, Inc. (ARTL) | $1.36M | -219.36% | -1595.51% | -649.28% | -119.09% |
| Genprex, Inc. (GNPX)vs › | $1.37M | -107.08% | -750.62% | -506.81% | -355.90% |
| INVO Fertility, Inc. (IVF)vs › | $1.48M | -28.43% | -37.81% | -267.17% | -197.37% |
| PMGC Holdings Inc. (ELAB)vs › | $1.49M | N/A | -48.91% | -66.07% | -87.70% |
| Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs › | $1.50M | -163.98% | N/A | N/A | N/A |
| Curis, Inc. (CRIS)vs › | $1.54M | -567.17% | -332.51% | -201.53% | -141.19% |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.17M | -709.40% | -164.13% | -164.13% | -164.13% |
| IM Cannabis Corp. (IMCC)vs › | $1.17M | -128.95% | -69.60% | -67.51% | -50.89% |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.14M | -9.45% | -4.19% | 5.39% | 5.39% |
| Clearmind Medicine Inc. (CMND)vs › | $1.11M | -60.41% | -162.02% | -321.37% | -223.75% |
ROIC
-219.4%
ROE
-253.6%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -219.36% |
| 2026-03-31 | -159.37% |
| 2025-09-30 | -4407.80% |
| 2025-03-31 | -1392.12% |
| 2024-12-31 | -345.45% |
| 2024-09-30 | -148.10% |
| 2024-06-30 | -148.32% |
| 2024-03-31 | -106.17% |
| 2023-12-31 | -84.50% |
| 2023-09-30 | -69.74% |
| 2023-06-30 | -61.12% |
| 2023-03-31 | -60.23% |
| 2022-12-31 | -52.95% |
| 2021-11-30 | -31.43% |
| 2021-08-31 | -61.46% |
| 2021-05-31 | -55.24% |
| 2021-02-28 | -41.09% |
| 2020-11-30 | -52.85% |
| 2020-08-31 | -120.92% |
| 2020-05-31 | -143.00% |
| 2020-02-29 | -124.10% |
| 2019-11-30 | -80.37% |
| 2019-08-31 | -58.77% |
| 2019-05-31 | -2192.47% |
| 2018-02-28 | -289.40% |
| 2017-11-30 | -169.61% |
| 2017-08-31 | -42.42% |
| 2017-02-28 | -305.96% |
| 2015-11-30 | -186.13% |
| 2015-08-31 | -99.68% |
| 2015-05-31 | -88.82% |
| 2015-02-28 | -255.65% |
| 2014-11-30 | -117.23% |
| 2014-08-31 | -126.04% |
